Survival Outcomes of Uterine Cervical Malignancies in Chinese Population

• Conditions: Uterine Cervical Neoplasms; Survival

• Registration Number: NCT03291236
• Lead Sponsor: Lei Li

Brief Summary

This study aims to determine survival outcomes (overall survival and progression-free survival) of primary malignancies of uterine cervix in China and relevant risk factors in a prospective cohort study.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-01-01
• Study First Submitted: 2017-09-20
• Study First Submitted QC: 2017-09-20
• Study First Posted: 2017-09-25
• Status Verified: 2018-02
• Last Update Submitted: 2018-02-07
• Last Update Posted: 2018-02-08
• Primary Completion: 2022-01-01
• Study Completion: 2023-01-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 5000

Inclusion Criteria

• Primary malignancies of uterine cervix.

Exclusion Criteria

• Secondary malignancies of uternie cervix.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall survival	5 years	Duration from diagnosis to recurrence
Progression-free survival	5 years	Duration from last treatment after remission to recurrence

Trial Locations

Locations (1)

Lei Li; 🇨🇳 Beijing, China/Beiing, China